| Term 
 
        | Penicillins Characteristics |  | Definition 
 
        | * Thiazolidine and beta lactam ring. Side chain determines properties and spectrum of activity * Inhibits transpeptidase * Bacteriocidal * Microbes make beta-lactamase, breaks open beta lactam ring. |  | 
        |  | 
        
        | Term 
 
        | Penicillin G: Aqueous Form |  | Definition 
 
        | * Procaine-complexed suspension for IM. Local anesthetic that helps numb pain of injection *Available w benzathine as Bicillin C-R * Ester form and can cause allergic reaction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Aqueous for IM/IV * Procaine *Benzathine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Bicillin LA, longer lastering, suspension for IM * 90% eliminated by tubular secretion, things that compete for secretion site ie. uric acid and probenecid increases PCN levels   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Dosed in Units 1 unit-.6 uG * Given as an IM or IV * Distributes to CNS only if the meninges are inflammed * Grand daddy of PCN |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * phenoxymethyl PCN * Acid stable form for oral use * Dose in mgs. * Food interferes with absorption of most PCNs so give 1hr before or after eating * Less active than "G" in some organisms |  | 
        |  | 
        
        | Term 
 
        | Penicillinase Resistant PCNs |  | Definition 
 
        | Dicloxacillin oral Oxacillin parenteral Nafcillin parenteral   Eliminated by biliary and renal excretion |  | 
        |  | 
        
        | Term 
 
        | Aminopenicillins Characteristics |  | Definition 
 
        | *Have an amino group * provide more activity against gram - bacteria * Still susceptible to PCNase * Ampicillin and Amoxicillin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * oral or IV * Available with Subactum or unasyn for IM IV to prevent beta lactamase activity.   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * beta lactamase resistor * preferable to ampicillin for peritonitis due to Bacteroides fragilis. *Parenteral |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Tablets, oral suspension, prediatric drop * Better oral absorption and longer half live than ampicillin * Available with Clavulanate (beta lactamase inhibitor) (Augmentin brand name) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Before dental work if high risk (prosthetic heart valve, cyanotic heart disease) * Otitis media * Forperitonitis orally AFTER IV thrapy to finish off infection |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Against pseudomona and some Proteus * susceptible to PCNases *Marketed with beta lactam inhibitor and parenteral * Ticarcillin+CLavulanate * Piperacillin+ Tazobactam (piperacillin sometimes given by itself) |  | 
        |  | 
        
        | Term 
 
        | General Side Effects of all PCNs |  | Definition 
 
        | * Hypersensitivity fomr metabolites acting as haptens. IgE mediated. * Diarrhea common to all antibiotics * Superinfection, especially with C. difficile * Seizures if penetrat BBB by blocking GABA inhibitor receptor * Jarisch-Herxheimer Reaction in 70-90% w 2 degree syphyllis.Self limiting, looks like allergic rxn |  | 
        |  | 
        
        | Term 
 
        | Cephalosporins Characteristics |  | Definition 
 
        | * Beta lactam and dihydrothiazine ring with side chain that has same function as PCNs * Can resist many beta lactamases, greater spectrum of activity * General 1-4, increasing in activity against gram Neg |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Resist Staph PCNase Cefazolin IV Cephalexin Oral Cefadroxil Oral   Good G+ and the PEcK gram- |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Less G+, HNPEcK Gram - * Cefalcor oral every 8 hf. Associated w serum sickness Cefuroxime- 12 h Cefoxitin- cephamycin. Acitve vs. Bacteroides fragilis, IV.IM * Cefotetan- IV.IM. Methylthiotetrazole side chain antagonizes vit K> hypoprothrombinemia. Give w K   |  | 
        |  | 
        
        | Term 
 
        | Cephalosporins Gen 3: Ceftriaxone |  | Definition 
 
        | Much less G+ more G- * Ceftriazone-IV/IM highly protein bound, can displace bilirubin. Not to <3 mo old. * Can use in those <3 mo for a single dose for gonorrhoeae conjunctivitis * good against meningitis, 50-50 bile, renal, do not use w Ca++ precipitates form in lung and kidney. * Sludge in children. nausea anorexia, epigastric pain, coli. Reversible when discountinues |  | 
        |  | 
        
        | Term 
 
        | Cephalosporins: Gen 3 other
 |  | Definition 
 
        | * Cefotaxime IV IM Parent and metabolit active> increase specturm * Cefpodoxime * Cefdinir excreted mostly unchanged. Binds Fe, decrease absorption, red feces with high Fe intake * Ceftazidime IV IM neurologic SE, increase risk if you are epileptic |  | 
        |  | 
        
        | Term 
 
        | Cephalosporins 4th Generation |  | Definition 
 
        | * For gram - rods *Save them as last resort * Cefepime: IV IM Good CNS penetration. Neuro side effects: disorientation, m yclonus, EFG, increased risk if epileptic. Mainly renal excretion * Cefditoren- pro RX, hydrolyzed by esterases during absorption |  | 
        |  | 
        
        | Term 
 
        | Advanced Generation Cephalosporin |  | Definition 
 
        | * Ceftaroline- IV proRx given every12 h for community acquired bacterial pneumonia and complicated skin and skin sturcture infection, MRSA * Side effects; Nausea, Diarrhea, rash |  | 
        |  | 
        
        | Term 
 
        | Cephalosporin General Side Effects |  | Definition 
 
        | * Hypersensitivity: Risk of cross allergy w PCN greatest for 1st gen. * Risk and avoid if you have documented type IgE to PCN * Immune mediated hemolytic anemia risk |  | 
        |  | 
        
        | Term 
 
        | Carbapenems Characteristics |  | Definition 
 
        | * Broad spectrum beta lactams. G+/G- microbes, reserved for resistent Impipenem only on needing with Cilastatin Meropenem Ertapenem Doripenem |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Note, most "statins' mean lower cholesterol. This DOESNT * Imipenem metabolized by dehydropeptidase with a toxic metabolite. Cilastatin inhibits this. * Cause nausea and vmitting side effects * Increase rick of infection with C. diff, seizures |  | 
        |  | 
        
        | Term 
 
        | Cardiopenems not needing Cilastatin |  | Definition 
 
        | * Meropenem- few seizures, not metabolized by dehydropeptidase * Ertapenem- once a day dosing * Doripenem- injection for complicated intra-abdominal infections andUTIs, newest |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Cardiopenem needing cilastatin with it. * IV/IM |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Resistant infectoins causing: 
UTIsLower RTIsBone, joint, skin intra abdominal and gynecological infectionbacterial septicemia |  | 
        |  |